ATE549638T1 - 13c-mr-bildgebung oder spektroskopie von zelltod - Google Patents

13c-mr-bildgebung oder spektroskopie von zelltod

Info

Publication number
ATE549638T1
ATE549638T1 AT07808605T AT07808605T ATE549638T1 AT E549638 T1 ATE549638 T1 AT E549638T1 AT 07808605 T AT07808605 T AT 07808605T AT 07808605 T AT07808605 T AT 07808605T AT E549638 T1 ATE549638 T1 AT E549638T1
Authority
AT
Austria
Prior art keywords
imaging
spectroscopy
cell death
pyruvate
relates
Prior art date
Application number
AT07808605T
Other languages
English (en)
Inventor
Kevin Brindle
Samuel Day
Mikko Kettunen
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE549638T1 publication Critical patent/ATE549638T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4828—Resolving the MR signals of different chemical species, e.g. water-fat imaging

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Signal Processing (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT07808605T 2006-08-18 2007-08-17 13c-mr-bildgebung oder spektroskopie von zelltod ATE549638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20063702 2006-08-18
PCT/NO2007/000286 WO2008020764A1 (en) 2006-08-18 2007-08-17 13c-mr imaging or spectroscopy of cell death

Publications (1)

Publication Number Publication Date
ATE549638T1 true ATE549638T1 (de) 2012-03-15

Family

ID=38690525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07808605T ATE549638T1 (de) 2006-08-18 2007-08-17 13c-mr-bildgebung oder spektroskopie von zelltod

Country Status (8)

Country Link
US (1) US8951500B2 (de)
EP (1) EP2052273B1 (de)
JP (1) JP5363320B2 (de)
CN (1) CN101506679B (de)
AT (1) ATE549638T1 (de)
ES (1) ES2381380T3 (de)
PL (1) PL2052273T3 (de)
WO (1) WO2008020764A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010501483A (ja) * 2006-08-18 2010-01-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ 乳酸塩及び過分極１３ｃ−ピルビン酸塩を含むイメージング剤
EP2107887A1 (de) * 2006-12-08 2009-10-14 Molecular Image Inc. Verfahren zur diagnose und überwachung von neurologischen erkrankungen mit magnetresonanz-verfahren
GB0713074D0 (en) * 2007-07-05 2007-08-15 Univ London A method of hyperpolarising a magnetic resonance agent
BRPI1013677A2 (pt) * 2009-04-02 2016-04-26 Ge Healthcare Ltd método para detectar inflamação ou infecção, e, usos de um 13c-piruvato hiperpolarizado, e de um meio de formação de imagem.
US20130209360A1 (en) * 2010-08-23 2013-08-15 The Regents Of The University Of California Compositions and Methods for Imaging
US9452409B2 (en) 2011-04-22 2016-09-27 Vanderbilt University Para-hydrogen polarizer
WO2014118258A1 (en) 2013-01-31 2014-08-07 Bracco Imaging Spa Hyperpolarized esters as metabolic markers in mr
EP3016687B1 (de) * 2013-07-01 2017-08-09 Bracco Imaging S.p.A Hyperpolarisiertes 1-13c-1,1-bis(acetoxy(methyl))-2,2'-cyclopropan als stoffwechselmarker für mr
EP2863229A1 (de) 2013-10-15 2015-04-22 Technische Universität München pH-Biosensoren auf Basis von Verbindungen mit pH-sensiblen Enolgruppen zur Magnetresonanzbildgebung und Spektroskopie und deren Verwendungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822816A (en) * 1987-04-10 1989-04-18 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin C
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US20040092549A1 (en) * 1999-08-30 2004-05-13 Jariwalla Raxit J Methods and compositions for selective cancer chemotherapy
KR101126952B1 (ko) * 2004-07-30 2012-03-20 지이 헬스케어 에이에스 건강한 조직과 종양 조직을 구별하기 위한 ｍｒ 영상화방법
ES2422558T3 (es) * 2004-11-19 2013-09-12 Ge Healthcare As Metodo de obtención de imágenes cardiacas con el uso de 13C-piruvato hiperpolarizado

Also Published As

Publication number Publication date
US20100226859A1 (en) 2010-09-09
CN101506679B (zh) 2013-03-06
WO2008020764A1 (en) 2008-02-21
CN101506679A (zh) 2009-08-12
EP2052273B1 (de) 2012-03-14
EP2052273A1 (de) 2009-04-29
JP5363320B2 (ja) 2013-12-11
US8951500B2 (en) 2015-02-10
ES2381380T3 (es) 2012-05-25
PL2052273T3 (pl) 2012-08-31
JP2010501482A (ja) 2010-01-21

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
GT201200189A (es) Antagonistas de pcsk9
NO20071127L (no) Triazoloftalaziner
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
CY1117721T1 (el) Κυτταρα προελευσης αμνιακου υγρου
PL2358756T3 (pl) Ludzkie przeciwciała o wysokim powinowactwie wobec pcsk9
JO3118B1 (ar) تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
CY1113074T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
CY1109985T1 (el) Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
ITMO20050067A1 (it) Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione.
MX351889B (es) Composiciones y métodos anti-cxcr1.
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
EP2516624A4 (de) Zelllinie 3m
DK2129391T3 (da) Diagnostisk fremgangsmåde
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
PL2052273T3 (pl) Obrazowanie lub spektroskopia metodą rezonansu magnetycznego 13C śmierci komórkowej